Real-time enrollment status for this hr+/her2- breast cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:40 AM UTC
| NCT Number | NCT07492641 |
| Recruiting Status | Recruiting |
| Condition | HR+/HER2- Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 1,056 participants |
| Active Locations | 21 sites in the US |
| Sponsor | BeOne Medicines |
| Last Updated on CT.gov | July 10, 2026 (3 days ago) |
As of July 13, 2026: Clinical trial NCT07492641 is currently recruiting participants. This clinical trial study for hr+/her2- breast cancer is actively seeking new participants at 21 locations across the United States. The study is sponsored by BeOne Medicines. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07492641 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07492641 was last updated 3 days ago (July 10, 2026). HelloStudys verifies this status automatically.